This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations of Soma Seal in Lung Cancer Treatment
Introduction
Soma Seal is an accomplished inventor based in Santiniketan, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lung cancer. His innovative work has led to the development of a unique pharmaceutical composition that shows promise in combating this serious disease.
Latest Patents
Soma Seal holds a patent for a synergistic pharmaceutical composition useful for the treatment of lung cancer. The invention comprises Compound C2 (Neo-isopulegol), C3 (Iso-pulegol), and C4 (Citronellol), which are derived from herbal seed extracts. This composition has demonstrated effectiveness in killing A549 lung cancer cells, either alone or in combination with the other compounds.
Career Highlights
Throughout his career, Soma Seal has worked with notable organizations such as the Council of Scientific and Industrial Research and Visva-Bharati. His experience in these institutions has allowed him to further his research and contribute to advancements in pharmaceutical sciences.
Collaborations
Soma Seal has collaborated with several professionals in his field, including Pranab Ram Bhattacharyya and Priyajit Chatterjee. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
Soma Seal's work in developing a synergistic pharmaceutical composition for lung cancer treatment highlights his dedication to advancing medical science. His contributions are paving the way for new therapeutic options in the fight against cancer.